Agreements reached under this partnership
Business alliance- 1
Evaluation of the biological functions of Neocella
- 2
Analysis of its mechanism of action and intercellular signaling
- 3
Study of a manufacturing process that takes quality stability into account
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
The impact of this transaction on the Company's consolidated results for the current fiscal year and subsequent fiscal years is currently under review. The Company will promptly make an announcement if any matter requiring disclosure arises.
| Item | Details |
|---|---|
| Name of alliance partner | Tokyo Medical University |
| Alliance partner's business activities | School corporations |
| Alliance partner's location | Shinjuku-ku, Tokyo |
| Type of alliance | Business alliance |
| Details of the alliance | Evaluation of the biological functions of Neocella, Analysis of its mechanism of action and intercellular signaling, Study of a manufacturing process that takes quality stability into account |
| Contract Date | 14 May 2026 |
| Impact on Business Performance | The impact of this transaction on the Company's consolidated results for the current fiscal year and subsequent fiscal years is currently under review. The Company will promptly make an announcement if any matter requiring disclosure arises. |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The agreement aims to clarify the biological functions and mechanisms of action of Neocella, examine its potential applications in human and animal fields, and establish a manufacturing process with excellent quality stability.